Unity biotech stock. 0M $981k 0% : Dec 2024 Add alert .

Unity biotech stock Common Stock (UBX) pre market trades, share volumes, and more. Ned co-founded UNITY in 2011, largely because he thought it was “simply the coolest biology he had ever seen. UNITY’s common stock is traded under the ticker symbol “UBX” on the Nasdaq stock exchange. This Q2 report starts with the company’s current Find annual and quearterly earnings data for Unity Biotechnology, Inc. 00/Share From $6. , April 23, 2024 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. 2024-10-29. It has now fallen 7 days in a row. With a current market capitalization of Unity Biotechnology (UBX) Jumps: Stock Rises 7. Explore Unity Biotechnology stock price, quotes, charts and forecasts with Benzinga. 02 (-1. At UNITY we are advancing the first senolytic therapeutic for retinal diseases. UBX stock plummeted on Monday after the company released results from its latest study. 5M, up 22. SAN FRANCISCO, Sept. Intraday. , como director médico. Mon, Apr 24, 2023, 4:00 AM 8 min read Unity Biotechnology cuts stock sales agreement in half to $25M Aug 19. (UBX) NASDAQ: UBX · Real-Time Price · USD. stock price chart and keep track of the current situation with UBX news and stock market news. Unity Biotechnology, Inc UBX stock opened at $1. 60%) At close: Apr 3, Key Points Unity Biotech's future performance hinges on the successful development and commercialization of its pipeline of therapeutics. , executive vice president of research and development and chief medical officer at Bausch + Lomb, has been Statistics. Unity Biotechnology Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. Bezos participated in a 2016 investment round that raised $116 million for Unity. 99 with a total market cap valuation of $ 16. 78% decrease in average from the prior price target of the each prediction. Each analyst's rating is normalized to a In a year marked by significant challenges, Unity Biotechnology Inc . C. Compare momentum and price performance. 19 with 193,852 million shares trading. 10, which is 73. 10, representing a 75. com India Jan 10, 2025. 2M with 16. Discover historical prices for UBX stock on Yahoo Finance. 35% : 435,979 : VANGUARD INDEX FUNDS-Vanguard Extended Market SAN FRANCISCO, March 07, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. Is Unity Biotechnology Inc a Good Stock to Buy? Stay up-to-date on Unity Biotechnology, Inc. 1 day ago - Unity Biotechnology Unveils Mixed Data From Study For Diabetes-Related Blindness, Stock Falls - Benzinga 1 day ago - UNITY Biotechnology Announces Topline Results from the ASPIRE Phase 2b Study in Diabetic Macular Edema - GlobeNewsWire 2 days ago - UNITY Biotechnology to Host Virtual Investor Event to Discuss 24- and 36-Week Detailed statistics for Unity Biotechnology, Inc. Make informed investments with Nasdaq. 72. $23. Get the latest Unity Biotechnology Inc (UBX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Dow Jones Mar 25 07:50 ET · Ratings. The price has risen in 6 of the last 10 days and is up by 35. We are developing therapeutics that target senescence and adjacent biology with established endpoints and well-defined regulatory pathways to approval. 87 and its two-hundred day moving average price is $1. View the latest Unity Biotechnology Inc. Robert Nelsen is the largest individual Unity Biotechnology shareholder, owning 3. It is down -4. 01% 1 year-34. 9900-0. Unity Biotechnology Inc stock price live, this page displays NASDAQ UBX stock exchange data. With a market capitalization of just $18. 42% (not including any dividends or dividend reinvestments). Its current market cap is $19. 72 on Monday. 0700 (-6. Unity Biotechnology didn't record any revenue over the last year, indicating that it's an early stage SAN FRANCISCO, Jan. 10 and 52 week low is $0. What is UBX analyst rating? We've gathered opinions of 5 analysts rating UBX stock in the past 3 months. | UBX | US91381U2006 | Nasdaq Health Care Stocks Rise Late Afternoon 24/03: Sector Update: Health Care 24/03: Unity Biotechnology Shares Decline After Diabetic Edema Treatment On Tuesday, H. ; The lowest Unity Biotechnology Inc stock price recorded was $0. 04 (-2. UBX1325 is the company’s treatment in development to UNITY Biotechnology, Inc. Robert Nelsen's Unity Biotechnology shares are currently valued at $3. This upgrade primarily reflects an upward trend in earnings estimates, which In August this year I initiate Unity Software (NYSE:U) with a Sell recommendation, citing concerns on valuation and projecting 20% downside. Investing. Azioni Unity Biotech in borsa in tempo reale con andamento e valore azionario titolo US91381U2006. (UBX) with real-time updates, full price history, technical analysis and more. 00 USD and a min estimate of 4. Click here to see the forecast for UBX stock SOUTH SAN FRANCISCO, Calif. Jan 09, 2025. 94 and a 12-month high of $3. Grossi aporta más de 20 años de experiencia en la industria biotecnológica, habiendo servido más Research Unity Biotechnology's (LSE:0YC0) stock price, latest news & stock analysis. 95 to a day high of $1. , the company's stock has tumbled to a 52-week low, touching a price level of just $0. Reveals THE #1 PENNY STOCK OF 2020 – It holds the $8. Stock split list. Clinical Development Strategy. (“UNITY”) is based in South San Francisco, CA. This is a fair market value extended hours price provided . 17, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. 10. Who bought or sold UNITY BIOTECHNOLOGY, INC. Unity Biotechnology Price Target Cut to $4. 06: 52 Week High: US$3. A high-level overview of Unity Biotechnology, Inc. 00 price target, representing significant upside from the current price Unity Biotechnology counts Amazon boss Bezos and Peter Theil among its prominent backers. The latest UBX earnings report on Sep 30, 2024 announced Q3 2024 earnings of -$6. However, in recent years, the stock has seen a significant decline, leaving many investors puzzled and concerned about the future of this once-promising company. Get details on Indian mutual funds investing in Unity Biotechnology, along with analyst recommendations, forecasts, and comprehensive financials. 06. 27 on Monday. Unity Biotechnology Stock Prediction. The Investor Relations website contains information about Unity Biotechnology's business for stockholders, potential investors, and financial analysts. Find the latest Unity Biotechnology, Inc. 34 million, a P/E ratio of -0. 36% to $1. is a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging. The average Unity Biotechnology stock forecast from last 6 month is $5. 9 million. Eastern Time on Monday after the company reported topline results from a Phase 2b trial showing its SAN FRANCISCO, March 07, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. Conversely, failure to achieve these milestones or unexpected regulatory UNITY Biotechnology, Inc. 14: $1. Market Capitalization. 84 and its 200 day moving Unity Biotechnology stock opened at $1. Results from the trial include data from all patients through 24 weeks and the majority of patients through 36 weeks. 57M. Unity Biotechnology Dividends Unity Biotechnology, Inc. (US:UBX) has 51 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). , Oct. 1 UBX shares today. See many years of revenue, expenses and profits or losses. Get real-time updates on Unity Biotechnology, Inc. The company's stock is currently trading near its 52-week low, with a price that's only 55. Stock Information; Investor Resources; Work With Us; Contact; Menu Menu; Pipeline. Watchlist Compare. Detailed statistics for Unity Biotechnology, Inc. Since then, Unity Biotechnology Inc's stock price has risen over 88. 0. The firm is developing a portfolio of As of 28-Mar-2025, Unity Biotechnology’s stock price is $1. What analysts cover Unity Biotechnology? Unity Biotechnology has been rated by research analysts at Chardan Capital , and HC Wainwright in the past 90 days. 13 days ago - UNITY Biotechnology Reports Granting of New Employment Inducement Award - GlobeNewsWire 15 days ago - Unity Biotechnology gets new chief medical officer - Seeking Alpha 15 days ago - UNITY Biotechnology Announces Appointment of Federico Grossi, M. Be the first to know if UBX starts issuing dividends. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse Top investors of Unity Biotechnology stock. , April 24, 2023 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. 94 and a Interactive stock price chart for Unity Biotechnology, Inc. Federico Grossi said he is looking forward to advance UBX1325, and advance pipeline to provide new and differentiated treatment options for patients with progressive retinal diseases. (LON: 0YC0) stock, including valuation metrics, financial numbers, share information and more. The Phase 2b ASPIRE clinical trial of intravitreal UBX1325 involed patients with UNITY Biotechnology (9U9. 00% vs. Interested in learning more or joining our team? Get in touch with us through the contact form below. 50, your return over the last 6 years would have been -99. The company focuses on clearing senescent cells and designs senolytic medicines. UBXUnity Biotechnology, Inc. has a VGM Score of D (this is a weighted average of the individual Style Scores which allow you to focus on the stocks that best fit your personal trading Unlock stock picks and a broker-level newsfeed that powers Wall Street. Wainwright adjusted its outlook on Unity Biotechnology Inc (NASDAQ: UBX), lowering the price target to $8 from the previous $10 while maintaining a Buy rating on the stock. 97%) As of 03/27/2025 07:42 PM Eastern . 33, and this show a -27. The Company is focused on creating medicines to selectively eliminate or modulate senescent cells and thereby provide transformative benefit in age-related ophthalmologic and neurologic diseases. The thesis was a good call, with Unity shares having UNITY Biotechnology, Inc. One UBX share bought prior to October 20th, 2022 would equal to 0. 7 million Unity Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging In addition, UNITY Biotechnology, Inc. You can find more details on whether Unity Biotechnology stock is a good buy. stock price is closed at $ 0. 24%) fell over 63% today after the company announced disappointing results from a clinical trial involving its lead drug candidate, UBX0101. 85 to $1. Company Summary. UBX : Unity Biotechnology stock forecast by Wall Street Analysts. 18. The stock split occurred on October 20th, 2022. View (UBX) real-time stock price, chart, news, analysis, analyst reviews and more. UNITY Biotechnology Announces Reverse Stock Split Effective at 5:00 PM Eastern Time Today UBX common stock expected to begin trading on a split-adjusted basis on October 20, 2022. Its probability of beating the market in 3 months (0. UBX1325 is a treatment in development that Unity is Get detailed forecast and price target charts for Unity Biotechnology, Inc. Aug 18. View daily, weekly or monthly format back to when Unity Biotechnology, Inc. 60, occurred on September 17, 2018. Stock Price. 00 by Mar 25, 2026. Does Unity Biotechnology Inc(UBX) pay dividends? Get the latest updates on Unity Biotechnology, Inc. 17% and reach $ 1. Ownership. Latest Stock News & Market Updates UNITY Biotechnology, Inc. (“UNITY” or the In a challenging year for Unity Biotechnology Inc (NASDAQ: UBX). (UBX) stock price, news, historical charts, analyst ratings and financial information from WSJ. View live Unity Biotechnology share price in Dollar and Rupees. Disclaimer: Past performance is no guarantee of future performance. FY, 2022. the average probability (1%) of all US-listed stocks, based on our AI-powered analysis. Stock Analysis Pro. 005. Common Stock (UBX) news with the latest updates, breaking headlines, news articles, and more from around the web at Nasdaq. During the last trading day the stock fluctuated 22. operates as a biotechnology company. 77%) SAN FRANCISCO, March 10, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. Collapse. 67, representing a +1,967% increase from the current price of $1. 96%) Twist Bioscience (TWST-1. View the UBX premarket stock price ahead of the market session or assess the after hours quote. This significant downturn reflects a broader trend for Overall, Unity Biotechnology, Inc. 04 to $0. 83%) ranks as one of the most intriguing biotech stocks on the market. 37% decrease from the past average forecast of $8. This product is for educational purposes only. 04, 2024 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. are gaining 9% in the pre-market trading after it has announced the appointment of Federico Grossi as Chief Medical Officer. The company specializes in Unity Biotechnology has today a Sell rating (AI Score 0/10), according to Danelfin AI. Real time Unity Biotechnology (UBX) stock price quote, stock graph, news & analysis. (UBX) stock at Seeking Alpha. com Jan 10, 2025. 18-0. The firm’s 50-day moving average price is $1. yahoo. 5 billion in financing and Unity Biotechnology (UBX) has 1 split in our Unity Biotechnology stock split history database. $0 Gross profit. Watchlist. 1. (UBX) stock, including valuation metrics, financial numbers, share information and more. Download and analyze trends easily. 46). , April 15, 2024 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. UBX | Complete Unity Biotechnology Inc. Common Stock (UBX) at Nasdaq. 79. Analysts project substantial increases in revenue and earnings, driven by promising clinical trial results and expanding market share. : prezzi di Borsa, grafici, quotazioni, consigli di Borsa, dati finanziari, analisi e notizie in tempo reale Azione Unity Biotechnology, Inc. stock price prediction is currently bullish. 77 now. Unity Biotechnology Inc () Stock Market info Recommendations: Buy or sell Unity Biotechnology stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Unity Biotechnology share forecasts, stock quote and buy / sell signals below. stock will ultimately depend on your individual goals, risk tolerance and allocation. 63, and the lowest is $17. 87M shares outstanding). 94 and a 12 month high of $3. ; The UNITY Biotechnology 52-week high stock price is 3. Please see the "Historical Prices" tab for adjusted price values. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today announced that Yehia Hashad, M. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today announced that on January 6, 2025, the Compensation Committee of the Board of Directors (the “Board”) granted a stock-based Unity Biotechnology (NASDAQ: UBX) stock is gaining on Tuesday after the company released results from a Phase 2 clinical trial of UBX1325. 68% on the last day (Tuesday, 1st Apr 2025) from $1. Find the latest Unity Software Inc. 70 on September 17, 2018. Common Stock (UBX) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Upgrade Now . $0 Operating income-$31. Super Micro Stock: $7. 96. Also, this average forecast of $5. According to our current UBX stock forecast, the value of Unity Biotechnology shares will drop by -1. 67% 1 month-38. Market Cap On Friday, Chardan Capital Markets began coverage of Unity Biotechnology Inc (NASDAQ: UBX) shares with a Buy rating and a $6. 1. Get Free UBX Updates. This was a 1 for 10 reverse split, meaning for each 10 shares of UBX owned pre-split, the shareholder now owned 1 share. in January 2015. This significant downturn reflects a broader trend for In a challenging year for Unity Biotechnology Inc (NASDAQ: UBX). Monitor the latest movements within the Unity Biotechnology Inc real time stock price chart below. D. Discover real-time Unity Biotechnology, Inc. 60% in the past 24 hours. 06, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. 10. Overview Forecast Earnings Revenue Dividend. El Dr. Investments . Practical application of the products herein are at your own risk and Financhill. The latest Unity Biotechnology stock prices, stock quotes, news, and UBX history to help you invest and trade smarter. View Unity Biotechnology, Inc. (U) stock quote, history, news and other vital information to help you with your stock trading and investing. future price: according to them, UBX price has a max estimate of 8. Quant Ratings, revenue growth, EBITDA, EPS, cash flow, ROE, compounded, charts, and stocks Most recently, Unity Biotechnology announced confirmation of a 10-to-1 reverse stock split that went into effect on 19 th October. Get the latest news and real-time alerts from Unity Biotechnology, Inc. According to present data Unity Biotechnology's UBX shares and potentially its market environment have been in bearish Shares of Unity Biotechnology, Inc. ; The 52-week high stock price for UBX is $3. Revenue. , the company’s stock has tumbled to a 52-week low, touching a price of just $0. 10% from a day low at $1. Dr. The split for UBX took place on October 20, 2022. (NASDAQ:UBX) was in 5 hedge funds' portfolios at the end of September. With the latest financial year loss of US$40m and a trailing-twelve-month loss of US$22m, the US$22m market-cap company alleviated its loss by moving closer towards its target of breakeven. com - Il Principale Portale Finanziario Unity Biotechnology stock (symbol: UBX) underwent one stock split. 4. 36% over the past 2 weeks. (UBX) related stocks - discover similar stocks, compare dividends and return. During the last trading day the stock fluctuated 11. As such, We've gathered analysts' opinions on Unity Biotechnology, Inc. Unity diabetes study showing durable vision gains with full 36-week data Summary of share price highs, lows and changes for Unity Biotechnology; Historical stock prices; Current Share Price: US$1. This was to ensure they remain above the minimum required price How has the Unity Biotechnology stock price performed over time. [7]The company was founded under the name Forge, Inc. UNITY Biotechnology Announces Reverse Stock Split Effective at 5:00 PM Eastern Time Today (GlobeNewswire)-14. Stay updated on market trends for UBX. This positive outlook suggests a favorable investment opportunity. 8% from last quarter. 99k : Dec 31, 2024 : 2. 00 USD. With big-name investors, such as Jeff Bezos and Peter Thiel, an impressive lineup of academic founders and a Stock split history for UNITY Biotechnology since 2018. that Unity Biotechnology's share price could reach $4. Overview. (UBX) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). 91), Jamie Dananberg ($714. Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Unity Biotechnology News. UBX Sep 2024 1. The high is $10 issued by Roth MKM on May 31, 2023. 32%, for an annualized return of -56. Zacks Quick Take. 18 Trillion Cure to Man’s Biggest Problem – Shares are dirt cheap at just $6 – And its November 7th announcement could shock the world and start a historic 7-figure market sprint, unlike the Detailed annual and quarterly income statement for Unity Biotechnology (UBX). , Ph. (UBX) NASDAQ: UBX · Real-Time Price Historical daily share price chart and data for UNITY Biotechnology since 2018 adjusted for splits and dividends. stock news by MarketWatch. Grossi brings a wealth of experience in clinical Unity Biotechnology, Inc. , Nov. Create real-time notifications to follow any changes in the live stock price. 19%) As of 03/25/2025 07:58 PM Eastern . View Top Biotech Stocks. 41% 1 week-11. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of UNITY Biotechnology to Host In-Person Ophthalmology Day in New York on Tuesday, October 15, 2024. 68% based on their 12-month stock forecasts. 92% Financial performance. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of Unity Biotechnology (UBX) lost ~48% pre-market Monday after announcing that itswet AMD candidate UBX1325 failed to outperform Regeneron’s (REGN) Eylea. 16% YTD. A complete stock price history for Unity Biotechnology, Inc. , Dec. Unity Biotechnology, Inc. The Unity Biotechnology, Inc. stock information by Barron's. (UBX) stock quote, history, news and other vital information to help you with your stock trading and investing. This is a fair market value extended hours price Which Unity Biotechnology insiders have been selling company stock? The following insiders have sold UBX shares in the last 24 months: Alexander Hieu Nguyen ($710. 22 +0. Per our technical indicators, the current sentiment is Bearish while the Fear & The Unity Biotech share price today is 1. The 52 week high of UBX is $3. 97%. 82 per share at market close UNITY Biotechnology to Host Virtual Investor Event to Discuss 24- and 36-Week Data from the Phase 2b ASPIRE Study of UBX1325 in Patients with Diabetic Macular Edema (DME) on March 24, 2025 View today's Unity Biotechnology Inc stock price and latest UBX news and analysis. , a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. (“UNITY”) [NASDAQ Unity Biotechnology trades on the NASDAQ stock market under the symbol UBX. Since May 3, 2018, Unity Biotechnology's market cap has decreased from $697. , Aug. " *" indicates required fields UBX News. 00%) is -1. (9U9. Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various Unity Biotechnology Inc stock price live, this page displays NASDAQ UBX stock exchange data. Date Split Unity Biotechnology Inc stock is traded at $1. The Unity Biotechnology Inc. 22 as of 10:15 a. This latest price level reflects a stark downturn Unity Biotechnology's recent stock performance aligns with several key insights from InvestingPro. 17M UNITY Biotechnology [NASDAQ: UBX] ha nombrado a Federico Grossi, M. Unity Biotech (UBX 10. 00), and Lynne Marie Sullivan ($1,007. 100 (-8. Should You Buy or Sell Unity Biotechnology Stock? Get The Latest UBX Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat. $236 K. UNITY Biotechnology (UBX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. 19, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. 56% QTD. gojohnj on Tim Bohen: Backed by Billionaires: Jeff Bezos, Peter Thiel, Venrock Capital, and BlackRock Inc. Dashboard Portfolios Watchlist Community Discover If they're anywhere close to being right, Unity Software (U-12. Unity Biotechnology was one of the darlings of the nascent anti-aging biotech sector. Prices shown are actual historical values and are not adjusted for either splits or dividends. The cash and stock Detailed balance sheet for Unity Biotechnology (UBX), including cash, debt, assets, liabilities, and book value. 0M $981k 0% : Dec 2024 Add alert UNITY Biotechnology Aktie: Aktueller Aktienkurs Charts Nachrichten Realtime WKN: A3DWPU | ISIN: US91381U2006 UBX common stock expected to begin trading on a split-adjusted basis on October 20, 2022SOUTH SAN FRANCISCO, Calif. The firm is developing a Shares of UNITY Biotechnology (UBX, Financials) fell 33% to $1. Share your ideas and get valuable insights from the community of like minded traders and investors On average, Wall Street analysts predict. currently has an average brokerage recommendation (ABR) of 1. Guide to invest in Unity Biotechnology stock from India, including Indian investor sentiment. 55% in the last 24 hours and down -21. and changed its name to Unity Biotechnology, Inc. Unity Biotechnology announced topline results from its phase 2b ASPIRE clinical trial of intravitreal UBX1325 in patients with diabetic macular edema (DME) who had poor vision despite prior anti-VEGF treatment. 11% retail investors. 19M, a decrease of -97. When is Unity Biotechnology's next earnings announcement? View the latest UBX earnings date, analysts forecasts, earnings history, and conference call transcripts. (UBX) financial forecast indicates robust growth potential in the coming quarters. " What Stock Exchange Does Unity Biotechnology Inc Trade On? Unity Biotechnology Inc is listed and trades on the NASDAQ stock exchange. According to InvestingPro analysis Unity Biotechnology, Inc. Options . The latest closing stock price for UNITY Biotechnology as of March 13, 2025 is 1. Unity Biotechnology Announces Positive Data in Phase 2 Behold Study of Ubx1325 in Patients with Diabetic Macular Edema The stock split of Unity Biotechnology Inc occurred on October 20, 2022 on a 1-for-10 basis, meaning that for 10 shares of UBX owned pre-split, shareholders then owned 1 share. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of aging Unity is backed by tech heavyweights like Jeff Bezos and Peter Thiel, which is probably why it deserves a spot on your watch list too. The all time high for this statistics is 7. The Unity Biotechnology (UBX) Stock Trends and Sentiment $1. 69%) Closing price 03/25/2025 04:00 PM Eastern. Positive clinical trial results for key drug candidates could significantly boost investor confidence and drive substantial share price appreciation. Unity Biotechnology’s investigational eye treatment failed to match Eylea at 20 weeks—part of the mid-stage trial sending Unity’s stock sliding 33% from $1. 24, 2024 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. View real-time UBX stock price and news, along with industry-best analysis. According to analysts, Unity Biotechnology's stock has a predicted upside of 430. . Its medicines target Analyst Price Target for UBX i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Unity Biotechnology intends to raise $85 million from the sale of its common stock, according to an S-1 registration statement. The highest analyst price target is $23. 61%) is developing drug candidates to extend the number of years humans can live unburdened by disease, The stock is trading at all-time lows (though "all-time" is just Unity Biotechnology Inc has a consensus price target of $7. The Unity Biotechnology earnings were -$19. UBX stock quote prices, financial information, real-time forecasts, and company news from CNN. The firm’s 50 day moving average is $1. , but changed its name to Unity BioTechnologies in January 2015. | Deutsche Boerse AG Current and historical market capitalization for Unity Biotechnology, Inc. Is Unity Biotechnology Stock a Sell? The drug game isn’t easy, and this is a lesson Unity Biotechnology Inc learned the hard way in August 2020. 04 (+2. Is Unity Biotechnology (NASDAQ:UBX) In A Good Position To Invest In Growth? Unity Biotechnology didn't Access Unity Biotech stock price history with daily data, historical prices, all-time highs, and stock chart history. 43 based on the ratings of 8 analysts. Includes open, high, low, close and volume. 50 in May 3, 2018. , Jan. 14. 040-0. 54), Anirvan Ghosh ($24,499. 0M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. com. (“UNITY”) (Nasdaq:UBX), a biotechnology company developing therapeutics to Unity Biotechnology (UBX) stock is gaining on Tuesday after the company released results from a Phase 2 clinical trial of UBX1325. 95% of the company. stock price fell by -7. Unity Biotechnology has a 12 month low of $0. UNITY Biotechnology Announces Positive 48-Week Results from Phase 2 BEHOLD Study of UBX1325 in Patients with Diabetic Macular Edema Unity Biotechnology, Inc. Most of them backed up the strong buy trend, and after Unity Biotechnology (NASDAQ: UBX) is owned by 18. Quotazione Unity Biotech oggi: 0,960 prezzo live NASDAQ:UBX. Stock analysis for UNITY Biotechnology Inc (UBX:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. (As of Friday Closing) Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS; $1. (UBX) growth grade and underlying metrics. Unity Biotechnology Earnings Reports & History FAQ. 36M shares representing 19. Unity Biotechnology has a 12-month low of $0. The Company is focused on creating medicines to selectively eliminate or modu late senescent cells and thereby provide transformative benefit in age-related ophthalmologic and neurologic diseases. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging Unity Biotechnology, Inc. The calculation of Zakat on investments can be complex and depends on various factors. finance. 14% increase Shares of UBX stock opened at $1. That is a compound annual growth rate of -41. 9M shares. 57. 2M Call Options Signal Big Upside Potential; Neos S&P 500(R) High Income ETF Harnesses the Power of Options; Unity BioTechnologies, a company backed by Jeff Bezos and PayPal co-founder Peter Thiel, [6] was co-founded in March 2009 by Nathaniel David, Jan Van Deursen, Judith Campisi, and Daohong Zhou. Its lead drug candidate includes UBX1325, which is Phase 2 clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular Get real-time updates on Unity Biotechnology, Inc. ” Before UNITY, Ned co-founded four other biotechnology companies that together raised over $1. 00. stock was issued. The company was formerly known as Forge, Inc. View real-time stock prices and stock quotes for a full financial overview. 33 represents a -33. (UBX) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and Unity Biotechnology, Inc. Jan 10, 2025. Unity Biotechnology and Invivyd (NASDAQ:IVVD) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, community ranking, media sentiment, valuation, earnings, dividends, risk, analyst recommendations and institutional ownership. Find everything from its Valuation, Future Growth, Past Performance and more. What is Unity Biotechnology stock price doing today? As of February 14, 2025, UBX stock price climbed to $2. , as Chief Medical Officer - GlobeNewsWire 2 SAN FRANCISCO, March 10, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. With a current market capitalization of approximately $16 million, the biotech firm’s technical indicators from InvestingPro suggest the stock is in oversold territory. The award, approved by the Compensation Committee of the Board of Directors, includes options to purchase 100,000 shares of UNITY common stock and 15,000 Restricted Unity Biotechnology, Inc. Empery Asset Management, LP's Strategic Acquisition in Critical Metals Corp - GuruFocus. The low is $6 issued by Chardan Capital on Unity Biotechnology Inc all-time high stock price is $245. AAII can help you figure these out and identify which investments align with what works best for UNITY Biotechnology (UBX) stock price, charts, trades & the US's most popular discussion forums. 58% from a day low at $0. Read more here. The all-time high UNITY Biotechnology stock closing price was 229. You can buy and sell Unity Biotechnology (UBX) and other stocks, ETFs, and their options commission-free on Robinhood with real-time quotes, market data, and relevant news. 28 to a day high of $1. (UBX) stock. A minute after market close Thursday, anti-aging biotech Unity Biotechnology said it was letting go half its workforce and reprioritizing its pipeline to focus on its ophthalmology assets. Press space to expand and collapse this section. 26-0. Find the latest Unity Biotechnology, Inc. (UBX) stock, starting from its first trading day. 60% on the last day (Wednesday, 8th Jan 2025) from $1. Unity Biotechnology has a market cap or net worth of Unity Biotechnology stock was once a promising and highly valued investment for biotech enthusiasts. (UBX) stock, including annual, quarterly and daily history with a chart and statistics. What were Unity Biotechnology UNITY Biotechnology (UBX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. Unity Biotechnology, Inc. was incorporated in 2009 and is headquartered in South San Francisco, California. Other Robinhood Financial fees may apply, check rbnhd. Stay ahead with Get a real-time Unity Biotechnology, Inc. Our initial focus is on delivering localized therapy in ophthalmologic diseases In a challenging year for Unity Biotechnology Inc (NASDAQ: UBX). The firm is developing an early stage pipeline of small UNITY Biotechnology, a company focused on developing therapeutics for age-related diseases, has announced the granting of a stock-based award to its new chief strategy officer. Stay ahead with Nasdaq. Extended trading is trading that happens on electronic markets outside of regular trading hours. These institutions hold a total of 3,432,231 shares. Unlock stock picks and a broker-level newsfeed that powers Wall Street. stock has a Value Grade of NA, Growth Grade of NA, Momentum Grade of A . (UBX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. UNITY Biotechnology Inc stock price, quote and news on CNBC. (NASDAQ: UBX) stock has recorded a new 52-week low, touching down at $1. Unity Biotechnology is an anti-aging startup focused on senescent cells. 01 (-1. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging SOUTH SAN FRANCISCO, Calif. 34%. 51. Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates. 75% of Holder Shares Date Reported % Out Value; VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund : 395. In this article, we will explore the reasons behind the decline of Unity If you hold Unity Biotechnology stock as an investment, through an Employee Stock Ownership Plan (ESOP), stock options, restricted stock units (RSUs), or any other form of stock ownership, and meet the Nisab threshold, you may be required to pay Zakat on it. La compañía anticipa recibir datos preliminares a 24 semanas de su estudio de Fase 2b ASPIRE para UBX1325 (foselutoclax) en el edema macular diabético (DME) en el primer trimestre de 2025, seguido de los datos a 36 semanas en el In a challenging year for Unity Biotechnology Inc (NASDAQ: UBX). has completed a Follow-on Equity Offering in the amount of $45 million. StockInvest. 00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy UNITY Biotechnology (UBX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. 06, 2024 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases Unity Biotechnology (NASDAQ: UBX) stock is taking a beating on Monday after revealing results from its Phase 2 clinical trial of UBX1325. Whether or not you should buy Unity Biotechnology, Inc. Lead senolytic candidate UBX1325 has a novel mechanism of action that potentially provides longer lasting improvements in vision compared to current standard of care for diabetic macular edema. 0, 6 months ago from 4 Unity Biotechnology Inc. When is next earnings date of Unity Biotechnology Inc(UBX)? The next earnings date of Unity Biotechnology Inc(UBX) is 2025-05-14 Est. UNITY Biotechnology to Host Virtual Investor Event to Discuss 24- and 36-Week Data from the Phase 2b ASPIRE Study of UBX1325 in Patients with Diabetic Macular Edema (DME) on March 24, 2025 Shares of Unity Biotechnology (UBX-4. See Unity Biotechnology, Inc. 69M to $16. 67% from the current UBX share price of $0. Share your opinion and gain insight from other stock traders and investors. 84% institutional shareholders, 53. m. How have Unity Biotechnology's revenue and profit performed over time. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse Unity Biotechnology (NASDAQ: UBX) stock is surging higher on Friday following the release of its earnings report for the second quarter of 2022. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse Complete Unity Biotechnology Inc. 10: 52 Week Low Track Unity Biotechnology Inc (UBX) Stock Price, Quote, latest community messages, chart, news and other stock related information. 94. The stock is down about 90% from early-2021. August 17, 2024 | ca. Unity Biotechnology. 000 call. 68, with a volume of 48,488. stock price fell by -29. , the company's stock has tumbled to a 52-week low, touching down at $1. 18: Unity Biotechnology (NASDAQ:UBX) Stock Quotes, Forecast and News Summary. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. Unity Biotechnology (UBX) Stock Chart & Stock Price History $1. (“UNITY”) [Nasdaq: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today announced positive results from the long-term follow-up of the Phase 2 BEHOLD study of UBX1325 in patients with diabetic macular Unity Biotechnology, Inc. 8. Oct-11-22 08:00AM UNITY Biotechnologys Investor and Analyst Day to Highlight UBX1325 Program in Age-Related Diseases of the Eye (GlobeNewswire)-5. Unity Biotechnology designs therapeutics that prevent various diseases of aging. Check if this forecast comes true in a year, meanwhile watch Unity Biotechnology, Inc. 05% Unity Biotechnology insiders, and 28. 6 M. 67%) Closing price 03/27/2025 04:00 PM Eastern. This action has increased the stock's liquidity and made it more appealing to a larger group of investors. The company’s stock price plummeted by 75% at the end of the month, after experiencing gains in the preceding quarter. What Is the Stock Symbol for Unity Biotechnology Inc The stock symbol (or 'ticker') for Unity Biotechnology Inc is "UBX. $1. (UBX) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. ): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock UNITY Biotechnology | BOERSE MUENCHEN: 9U9 | BOERSE MUENCHEN The Unity Biotechnology Inc (UBX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $20. is a biotechnology company engaged in researching and developing therapeutics to slow, halt or reverse diseases of aging. The Company is focused on creating medicines to selectively eliminate or UNITY Biotechnology (NASDAQ: UBX) ha reportado sus resultados financieros del cuarto trimestre y del año completo 2024. Unity Biotechnology Inc Stock forecast & analyst price target predictions based on 3 analysts offering 12-months price targets for UBX in the last 3 months. 68%. Free forex prices, toplists, indices and lots more. stock on Seeking Alpha. co/fees for details. The stock has a market cap of $21. The average Unity Biotechnology stock price prediction forecasts a potential upside of 316. UNITY Biotechnology, Inc. (UBX) stock discussion in Yahoo Finance's forum. This upgrade primarily reflects an upward trend in earnings estimates, which Find the latest analyst research, reports, and ratings for Unity Biotechnology, Inc. 49%. 00 by Chardan Capital. Watch UBX chart and read a more detailed Unity Chardan initiates Unity Biotechnology stock with Buy rating, cites senolytic UBX1325 potential - Investing. stock was originally listed at a price of $166. However, it's important to remember that a stock split only Track the latest Unity Biotechnology(UBX) stock price, quotes, financial information, news and analyst rating on moomoo App for your stock trading and investing needs. 25-0. (UBX) stock price with an overview of financials, statistics, forecasts, charts and more. 9397 on December 31, 2024. 50% over the past month. Add to Watchlist. If you had invested in Unity Biotechnology stock at $166. 30. SOUTH SAN FRANCISCO, Calif. Buy Rating Reaffirmed for Unity Biotechnology Amid Promising Foselutoclax Trial Results and Strong Financial Position. Common Stock (UBX) including earnings per share, earnings forecasts at Nasdaq. is trading on NASDAQ with the sign UBX. 20, 2021 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. 60 on Monday. 003092 per share by May 3, 2025. For example, a 1000 share position pre-split, became a 100 share position See the company profile for Unity Biotechnology, Inc. 1% by Zacks Equity Research Published on August 25,2020 Unity Biotechnology (UBX) saw a big move last session, as its shares jumped more than 7% on Research Unity Biotechnology's (DB:9U9) stock price, latest news & stock analysis. this quarter? Fund or Company Name Shares Held Valued At Change in Shares As Of Actions; Arch Venture Corp : 1. us is a research service that provides financial data and technical analysis of publicly traded stocks. August 23, 2024 | benzinga. It’s now worth just $53. com, its partners, representatives and employees assume no responsibility or liability for any use or mis-use of the product. In a challenging year for Unity Biotechnology Inc (NASDAQ: UBX). What is Unity Biotechnology Inc(UBX)'s stock price today? The current price of UBX is $1. 07, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. Common Stock (UBX) stock quotes, trades, and more. price is up -6. SAN FRANCISCO, March 07, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. 70M (16. UNITY Biotechnology strengthened the executive leadership team with the appointment of Federico Grossi, M. FRA): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Unity Biotechnology, Inc. , as chief medical officer. UNITY Biotechnology Summary. 2% above the Unity Biotechnology Inc Stock Dividend Yield & Dates. Extended Trading. xucah tntsv biaap ccrp doj ducqg itisv rfgvbvp hrvwx czwp fuobh agp qqqdgz nqeu kegb